Joyce Yablunsky
Psychiatric/Mental Health · Philadelphia, PANPI 1891967485
Payments from drug & device makers
Across 195 payments — averaging $23.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$609
- Corium, LLC$463
- Neurocrine Biosciences, Inc.$372
- Takeda Pharmaceuticals U.S.A., Inc.$272
- Axsome Therapeutics, Inc.$202
- plus $1K from 16 others
What the payments were for
- Food & beverage$4,658100%
- Education$30%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,662 in reported general payments places this provider in the 90th percentile of 1,041 psychiatric/mental health providers in Pennsylvania.
See all psychiatric/mental health providers in Pennsylvania →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 21 | $873 |
| Modafinil | 11 | $807 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 29 | $740 |
| Bupropion XlBupropion Hcl | 33 | $538 |
| Mirtazapine | 19 | $453 |
| Fluoxetine Hcl | 16 | $292 |
| Trazodone Hcl | 16 | $235 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 18 | $223 |
| Clonazepam | 41 | $214 |
| Sertraline Hcl | 21 | $153 |
| Hydroxyzine Hcl | 16 | $152 |
| Alprazolam | 36 | $145 |
| Divalproex Sodium | 11 | $133 |
| Escitalopram Oxalate | 17 | $88 |
| Gabapentin | 16 | $76 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Almatica Pharma LLCSertraline Hcl | $13 | $15321 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,041 psychiatric/mental health providers in Pennsylvania.
Other psychiatric/mental health in Philadelphia
- Andrew RenziPhiladelphia$13K
- Clement JohnPhiladelphia$13K
- Rena LindenPhiladelphia$9K
- Gordon ZeisPhiladelphia$8K
- Kimberly GarciaAllentown$573K
- Cortney SmithWashington$227K
- Britney KeplerPittsburgh$158K
- Kirstyn KamegBethel Park$136K
- Anna DipietroDowningtown$131K
- Deena MasciocchiLanghorne$71K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.